Blue Sparrows MedTech Fund

The Blue Sparrows MedTech Fund invests money and experience in very early-stage medtech companies. The fund is unique in the fact that besides 2 experienced fund managers, a total of 7 young entrepreneurs in medical technology are part of the fund. The aim is to use their recent experience for the purpose of the investments made in the fund.

van Oorschot, Thijs

Partner (Investor and Coach)

1 past transactions

Amber Implants

Series A in 2022
Amber Implants is a medical technology company located in The Netherlands. At Amber Implants, we design advanced spinal implants with porous structures using Additive Manufacturing (AM) technology. Currently, we are developing our first product VCFix: the new generation and only cementless treatment of patients with vertebral compression fracture. We are currently undergoing preclinical validation and will start our clinical trials in 2022.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.